Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,726.40
(
-1.68%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
106.58
(
5.89%
)
Bitcoin
70,957.40
(
-4.05%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

zipjet

Send PM Follow Ignore
Followers 36
Posts 2637
Boards Moderated 0
Alias Born 10/06/2003

zipjet

Re: DewDiligence post# 77280

Tuesday, 05/05/2009 5:40:10 PM

Tuesday, May 05, 2009 5:40:10 PM

Post# of 257257
>>Copaxone Continues to Clean Tysabri’s Clock in US Market

That is the key for stockholders of TEVA, with as you note, implications for MNTA.

For me, watching my wife slowly decline and continue to exacerbate on Copaxone stands in stark contrast to watching her get stronger, get her balance back and improve on Tysabri. She does experience frequent colds - something she never had on Copaxone but it is a reasonable exchange for her.

ij

There are times when rules and precedents cannot be broken; others when they cannot be adhered to with safety. (Thomas Joplin)

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now